Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Inventory (2017 - 2025)

ImmunityBio (IBRX) has disclosed Inventory for 5 consecutive years, with $910000.0 as the latest value for Q4 2025.

  • Quarterly Inventory fell 89.0% to $910000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $910000.0 through Dec 2025, down 89.0% year-over-year, with the annual reading at $910000.0 for FY2025, 89.0% down from the prior year.
  • Inventory for Q4 2025 was $910000.0 at ImmunityBio, down from $6.7 million in the prior quarter.
  • The five-year high for Inventory was $8.4 million in Q1 2025, with the low at $910000.0 in Q4 2025.